The latest generic entry comes on the heels of a new report from ICER, which published a list of prescription drugs that had substantial price increases in 2017 and 2018 without what they consider to be new supporting evidence.
from Front page feed https://ift.tt/2OTU6Sm
from Front page feed https://ift.tt/2OTU6Sm
Comments
Post a Comment